Kanaide H, Kobayashi S, Nishimura J, Hasegawa M, Shogakiuchi Y, Matsumoto T, Nakamura M
Research Institute of Angiocardiology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Circ Res. 1988 Jul;63(1):16-26. doi: 10.1161/01.res.63.1.16.
We investigated the effects of the Ca2+ antagonists diltiazem and verapamil on release of Ca2+ from intracellular store sites of rat aorta vascular smooth muscle cells in primary culture. Using the microfluorometry of Ca2+-indicator dye quin2, relative changes in cytosolic Ca2+ concentration could be measured. In the presence of 1 mM extracellular Ca2+, both diltiazem (IC50, 0.31 microM) and verapamil (IC50, 0.47 microM) dose-dependently inhibited elevations in the cytosolic Ca2+, as induced by depolarization of the plasma membrane with high extracellular K+. In the absence of extracellular Ca2+, caffeine and high extracellular K+ induced transient and dose-dependent elevations of the cytosolic Ca2+, and these elevations were not inhibited by either diltiazem or verapamil. Norepinephrine also induced a transient and dose-dependent elevation of cytosolic Ca2+ in the absence of extracellular Ca2+. However, this elevation was inhibited by verapamil and diltiazem (when the norepinephrine concentration was 10(-5) M, IC50 for verapamil and diltiazem was 4.0 and 24.9 microM, respectively). Thus, while verapamil and diltiazem may have no direct effect on the release of Ca2+ from the depolarization- and the caffeine-sensitive intracellular Ca2+ storage sites, the agents do seem to inhibit the adrenoceptor-mediated Ca2+ release mechanism in vascular smooth muscle cells.
我们研究了钙离子拮抗剂地尔硫䓬和维拉帕米对原代培养的大鼠主动脉血管平滑肌细胞胞内储存部位钙离子释放的影响。使用钙离子指示剂染料喹啉-2的显微荧光测定法,可以测量胞质钙离子浓度的相对变化。在存在1 mM细胞外钙离子的情况下,地尔硫䓬(IC50,0.31 microM)和维拉帕米(IC50,0.47 microM)均呈剂量依赖性地抑制了因细胞外高钾使质膜去极化所诱导的胞质钙离子升高。在不存在细胞外钙离子的情况下,咖啡因和细胞外高钾诱导了胞质钙离子的瞬时且剂量依赖性升高,并且这些升高不受地尔硫䓬或维拉帕米的抑制。去甲肾上腺素在不存在细胞外钙离子的情况下也诱导了胞质钙离子的瞬时且剂量依赖性升高。然而这种升高受到维拉帕米和地尔硫䓬的抑制(当去甲肾上腺素浓度为10^(-5) M时,维拉帕米和地尔硫䓬的IC50分别为4.0和24. microM)。因此,虽然维拉帕米和地尔硫䓬可能对去极化和咖啡因敏感的胞内钙离子储存部位的钙离子释放没有直接影响,但这些药物似乎确实抑制了血管平滑肌细胞中肾上腺素能受体介导的钙离子释放机制。